In yesterday’s Wall Street session, Teladoc Health Inc (NYSE:TDOC) shares traded at $7.95, down -7.45% from the previous session.
TDOC stock price is now -20.82% away from the 50-day moving average and -48.13% away from the 200-day moving average. The market capitalization of the company currently stands at $1.36B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $22, Cantor Fitzgerald recently initiated with Overweight rating for Teladoc Health Inc (NYSE: TDOC). On February 26, 2024, Leerink Partners recently initiated its ‘Market Perform’ rating on the stock quoting a target price of $17, while ‘DA Davidson’ rates the stock as ‘Neutral’
In other news, Kornwasser Laizer, Officer bought 10,879 shares of the company’s stock on Aug 02 ’24. The stock was bought for $88,579 at an average price of $8.14. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 02 ’24, Officer Waters Michael Willem bought 6,053 shares of the business’s stock. A total of $49,285 was incurred on buying the stock at an average price of $8.14. A total of 1.34% of the company’s stock is owned by insiders.
During the past 12 months, Teladoc Health Inc has had a low of $8.13 and a high of $27.36. As of last week, the company has a debt-to-equity ratio of 1.06, a current ratio of 1.62, and a quick ratio of 1.59. The fifty day moving average price for TDOC is $9.963 and a two-hundred day moving average price translates $15.27195 for the stock.
The latest earnings results from Teladoc Health Inc (NYSE: TDOC) was released for 2024-06-30. The net profit margin was -38.54% and return on equity was -52.96% for TDOC. The company reported revenue of $642.44 million for the quarter, compared to $652.41 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -1.53 percent.
